Dr. Freedman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
44 Binney St
Dana 710-C
Boston, MA 02115Phone+1 617-582-8598
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1998 - 2002
University of Pennsylvania Health SystemResidency, Internal Medicine, 1996 - 1998
University of Michigan Medical SchoolClass of 1996
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2011
Publications & Presentations
PubMed
- Frequent CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression.Miklos Diossy, Viktoria Tisza, Hua Li, Pranshu Sahgal, Jia Zhou
NPJ Precision Oncology. 2024-09-19 - 1 citationsDetecting Small Cell Transformation in Patients with Advanced EGFR Mutant Lung Adenocarcinoma through Epigenomic cfDNA Profiling.Talal El Zarif, Catherine B Meador, Xintao Qiu, Ji-Heui Seo, Matthew P Davidsohn
Clinical Cancer Research. 2024-09-03 - MYBL2 Drives Prostate Cancer Plasticity: Inhibiting Its Transcriptional Target CDK2 for RB1-Deficient Neuroendocrine Prostate Cancer.Beatriz German, Sarah A Alaiwi, Kun-Lin Ho, Jagpreet S Nanda, Marcos A Fonseca
Cancer Research Communications. 2024-09-01
Press Mentions
Prostate Cancer Metastasis Linked to Revival of Dormant Molecular ProgramJuly 19th, 2020
Grant Support
- P-2: Genetic And Clinical Characterization Of The 8q24 Prostate Cancer Risk LocusNational Cancer Institute2010–2011
- Elucidating Loci Involved In Prostate Cancer SuceptibilityNational Cancer Institute2010–2011
- Discovery, Biology And Risk Of Inherited Variants In Breast CancerNational Cancer Institute2010–2011
- Genetic And Clinical Characterization Of The 8q24 Prostate Cancer Risk LocusNational Cancer Institute2007–2009
- FINE Mapping And Characterization Of The 8q24 Prostate Cancer Risk LocusNational Cancer Institute2007–2009
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
